Related references
Note: Only part of the references are listed.Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers
Chong Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers
Patrick A. Gladding et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Acetylation of prostaglandnin H2 synthases by aspirin is inhibited by redox cycling of the peroxidase
Manju Bala et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry:: application to pharmacokinetic study of Astrix® in Korean healthy volunteers
Soo Kyung Bae et al.
BIOMEDICAL CHROMATOGRAPHY (2008)
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials - The cross trial safety analysis
Scott D. Solomon et al.
CIRCULATION (2008)
Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal antiinflammatory drug
H. Suleyman et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Non-redundant functions of cyclooxygenases: Oxygenation of endocannabinoids
Carol A. Rouzer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events
Francis M. Gengo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Nutritionally essential fatty acids and biologically indispensable cyclooxygenases
William L. Smith
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Sturctural basis of enantioselective inhibition of cyclooxygenase-1 S-α-Substituted indomethacin ethanolamides
Christine A. Harman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products
Masayuki Wada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Ian W. Davis et al.
NUCLEIC ACIDS RESEARCH (2007)
Prostaglandin endoperoxide H synthases -: Peroxidase hydroperoxide specificity and cyclooxygenase activation
Jiayan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Control of oxygenation in lipoxygenase and cyclooxygenase catalysis
Claus Schneider et al.
CHEMISTRY & BIOLOGY (2007)
The cyclooxygenase 2 genetic variant-765G>C does not modulate the effects of celecoxib on prostaglandin E2 production
Carsten Skarke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Partnering between monomers of cyclooxygenase-2 homodimers
C Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Divergent cyclooxygenase responses to fatty acid structure and peroxide level in fish and mammalian prostaglandin H synthases
Wen Liu et al.
FASEB JOURNAL (2006)
Likelihood-enhanced fast translation functions
AJ McCoy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Crystal structure of arachidonic acid bound to a mutant of prostaglandin endoperoxide H synthase-1 that forms predominantly 11-hydroperoxyeicosatetraenoic acid
CA Harman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases
CA Rouzer et al.
CHEMICAL REVIEWS (2003)
The cyclooxygenase reaction mechanism
WA van der Donk et al.
BIOCHEMISTRY (2002)
PHENIX:: building new software for automated crystallographic structure determination
PD Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1
T Burde et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
F Catella-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin
M Ouellet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries
JK Hennan et al.
CIRCULATION (2001)
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors
MC Walker et al.
BIOCHEMICAL JOURNAL (2001)
Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs
M Rosenstock et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
The productive conformation of arachidonic acid bound to prostaglandin synthase
MG Malkowski et al.
SCIENCE (2000)
Share Paper
